About: ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 2015 (uk) im November 2014 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q57642222-C425B6E8-5D7C-41DC-AC53-9D1126357B47
publication date	2014-11-13 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57642222-6BCCFBCA-A8D6-4930-B901-7FEB8587ABEA
language of work or name	English
exact match	wds:Q57642222-FD53EDA0-9CDD-4EA1-A6C7-06A686CF5284
exact match	https://scigraph.springernature.com/pub.10.1038/gim.2014.151
cites work	wds:Q57642222-95EC76E2-6588-4C7B-A2DD-4250D60F69E0 wds:Q57642222-EE3B3067-9D0B-4486-A63A-F1DA1E54C468
cites work	Anticipate and communicate: Ethical management of incidental and secondary findings in the clinical, research, and direct-to-consumer contexts (December 2013 report of the Presidential Commission for the Study of Bioethical Issues). Reporting genomic secondary findings: ACMG members weigh in.
author name string	wds:Q57642222-E43E148D-8687-40B5-9980-EC1498C6B916
author name string	ACMG Board of Directors
rdfs:label	ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing (en) ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing (nl)
skos:prefLabel	ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing (en) ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing (nl)
name	ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing (en) ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing (nl)
title	wds:Q57642222-39BFCFA4-DECE-43C0-840B-5FF2D6F3D01A
title	ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing (en)
page(s)	wds:Q57642222-FB8B8FE0-0950-4FC2-9199-1A8010EC7DDB
page(s)	68-69
instance of	wds:Q57642222-E3A0037E-2E3D-480C-BE5C-0CD100B94375
instance of	scholarly article
PubMed ID	wds:Q57642222-739B513F-44BE-4003-8BB9-C9E99AD9E15B
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25356965
PubMed ID	25356965
published in	wds:Q57642222-5DAC5648-3AE6-47A1-88A0-DA6AEDE3E15B
published in	Genetics in Medicine
issue	wds:Q57642222-FB7BBC65-E784-45F7-B57C-8247B4115A06
volume	wds:Q57642222-72DF1074-8E90-4C4E-8014-1C7DC5EB0B62
issue	1
volume	17
DOI	wds:Q57642222-9094D0D1-EB41-40D9-934F-5919EDE8FC11
DOI	http://dx.doi.org/10.1038/GIM.2014.151
DOI	10.1038/GIM.2014.151
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57642222
is cites work of	Getting personal: Head and neck cancer management in the era of genomic medicine Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans Returning a Research Participant's Genomic Results to Relatives: Analysis and Recommendations Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics Professionally Responsible Disclosure of Genomic Sequencing Results in Pediatric Practice Clinical exome sequencing in neurogenetic and neuropsychiatric disorders Unsolved challenges of clinical whole-exome sequencing: a systematic literature review of end-users' views Decoding mechanisms by which silent codon changes influence protein biogenesis and function Experiences with obtaining informed consent for genomic sequencing. Looking for Trouble and Finding It. Ethical Considerations for the Return of Incidental Findings in Ophthalmic Genomic Research Making genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of comparative effectiveness research "Not Tied Up Neatly with a Bow": Professionals' Challenging Cases in Informed Consent for Genomic Sequencing Clinical Next Generation Sequencing for Precision Medicine in Cancer Research participant interest in primary, secondary, and incidental genomic findings. Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial Return of genetic testing results in the era of whole-genome sequencing Unsolicited findings of next-generation sequencing for tumor analysis within a Dutch consortium: clinical daily practice reconsidered Mapping the Ethics of Translational Genomics: Situating Return of Results and Navigating the Research-Clinical Divide A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology Early somatic mosaicism is a rare cause of long-QT syndrome Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients Recommendations for the integration of genomics into clinical practice Genetic analysis of CHARGE syndrome identifies overlapping molecular biology. Choices for return of primary and secondary genomic research results of 790 members of families with Mendelian disease. Aggregate penetrance of genomic variants for actionable disorders in European and African Americans Effect of Public Deliberation on Attitudes toward Return of Secondary Results in Genomic Sequencing. Next Generation Sequencing in the Clinic Genomic sequencing in clinical practice: applications, challenges, and opportunities Clinical genome sequencing and population preferences for information about 'incidental' findings-From medically actionable genes (MAGs) to patient actionable genes (PAGs) Lost in translation: returning germline genetic results in genome-scale cancer research The ethics weathervane Genome Sequencing Technologies and Nursing: What Are the Roles of Nurses and Nurse Scientists? Parental attitudes and expectations towards receiving genomic test results in healthy children. Management of Incidental Findings in the Era of Next-generation Sequencing Novel and de novo mutations in pediatric refractory epilepsy Integrating precision cancer medicine into healthcare-policy, practice, and research challenges A Tale of Two Capacities: Including Children and Decisionally Vulnerable Adults in Biomedical Research Evaluation of exome filtering techniques for the analysis of clinically relevant genes. Prioritising the application of genomic medicine. Factors influencing NCGENES research participants' requests for non-medically actionable secondary findings. What are people willing to pay for whole-genome sequencing information, and who decides what they receive? Points-to-consider on the return of results in epigenetic research Next-Generation Sequencing and the Return of Results Informed consent for next-generation nucleotide sequencing studies: Aiding communication between participants and investigators Privacy and ethical challenges in next-generation sequencing Clinical application of next-generation sequencing for Mendelian diseases Sharing health-related data: a privacy test? Attitudes toward and current status of disclosure of secondary findings from next-generation sequencing: a nation-wide survey of clinical genetics professionals in Japan Criteria for reporting incidental findings in clinical exome sequencing - a focus group study on professional practices and perspectives in Belgian genetic centres Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations High-depth African genomes inform human migration and health A Clinical Service to Support the Return of Secondary Genomic Findings in Human Research Interest and Attitudes of Patients With Advanced Cancer With Regard to Secondary Germline Findings From Tumor Genomic Profiling Societal preferences for the return of incidental findings from clinical genomic sequencing: a discrete-choice experiment Research Participants' Preferences for Hypothetical Secondary Results from Genomic Research Actionable Genes, Core Databases, and Locus-Specific Databases. Stakeholders in psychiatry and their attitudes toward receiving pertinent and incident findings in genomic research.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software